Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials (Q43149607)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 February 2010
edit
Language Label Description Also known as
English
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials
scientific article published on 23 February 2010

    Statements

    Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials (English)
    Teresa Gerlock
    Lineke Zuurman
    M Angelyn Bethel
    Rury R Holman
    23 February 2010
    124-132

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit